Conversely, knockdown of CAMK2B using siRNA-CAMK2B significantly enhanced the proliferative, invasive, and migratory capabilities of glioma cells in both in vitro and in vivo settings, enhancing these abilities by 1.5 to 3 times. Here, CAMK2B is linked to central nervous system cancer.